1-4 of 4
Amy Gudger
Close
Sort by
Journal Articles

Isatuximab with Pomalidomide and Dexamethasone Provides Comparable Efficacy Outcomes in Frail Routine Care Myeloma Patients in a UK-Wide Cohort

Alexandros Rampotas, Alexandros Rampotas, Grant Vallance, Fotios Panitsas, Nanda Basker, Gina Sangha, Beena Salhan, Farheen Karim, Firas Al-Kaisi, Amy Gudger, Loretta Ngu, Matt Poynton, Ho Pui Jeff Lam, Lowri Morgan, Laura Yang, Jennifer Young, Mairi Walker, Ismini Tsagkaraki, Laura Anderson, Saleena Rani Chauhan, Rebecca Maddams, Richard Soutar, Margarita Triantafillou, Steve Prideaux, Abubaker Obeidalla, Ceri Bygrave, Supratik Basu, Karthik Ramasamy
Journal: Blood
Blood (2022) 140 (Supplement 1): 5206–5207.
https://doi.org/10.1182/blood-2022-163025
Published: 2022
Journal Articles

Efficacy Outcomes of Isatuximab with Pomalidomide and Dexamethasone Are Comparable to (ICARIA-MM) Trial Data: Initial Results of a UK-Wide Real-World Study of Relapsed Myeloma Patients

Faouzi Djebbari, Grant Vallance, Nanda Basker, Fotios Panitsas, Alexandros Rampotas, Gina Sangha, Beena Salhan, Farheen Karim, Firas Al-kaisi, Amy Gudger, Loretta Ngu, Matt Poynton, Ho Pui Jeff Lam, Lowri Morgan, Laura Yang, Jennifer Young, Mairi Walker, Ismini Tsagkaraki, Laura Anderson, Saleena Rani Chauhan, Rebecca Maddams, Lesley Stirton, Margarita Triantafillou, Steve Prideaux, Abubaker Obeidalla, Ceri Bygrave, Supratik Basu, Karthik Ramasamy
Journal: Blood
Blood (2021) 138 (Supplement 1): 1963.
https://doi.org/10.1182/blood-2021-145408
Published: 2021
Journal Articles

Split Mixed Donor Chimerism Early after T-Cell Depleted Reduced Intensity Conditioned Allogeneic Haematopoietic Stem Cell Transplantation Predicts Survival

Francesca A M Kinsella, MBChB, PhD MRCP, Amy Gudger, MBBS, MRCP, Charlotte F Inman, PhD, Graham Mc Ilroy, MBChB, PhD, Sandeep Nagra, MD, Jane Nunnick, Dave Waldron, Kerry Wall, Mike Griffiths, Paul Moss, MDPhD, Charles Craddock, MDPhD, Emmanouil Nikolousis, PhD, Ram Malladi, MBBS, PhD MRCP
Journal: Blood
Blood (2014) 124 (21): 423.
https://doi.org/10.1182/blood.V124.21.423.423
Published: 2014
Journal Articles

Full Donor T Cell Chimerism Predicts Transplant Outcomes In High Risk AML But Not In Intermediate Risk AML After a T-Deplete Alemtuzumab Conditioned Transplant

Amy Gudger, Vidhya Murthy, Duncan J Murray, MA MRCP, Ben Bailiff, Maria Mushkbar, Jonathan ray Lancashire, MBBS, MRCP, Phillip Nicolson, Kathy Holder, Lynda Baker, Lynn Bratby, Bhuvan Kishore, Richard Lovell, Shankaranarayana Paneesha, Nikolousis Emmanouil, MRCP, FRCPath, Ph.D
Journal: Blood
Blood (2013) 122 (21): 5545.
https://doi.org/10.1182/blood.V122.21.5545.5545
Published: 2013